AU Patent

AU2012209412A1 — Highly penetrating compositions and methods for treating pathogen-induced disordered tissues

Assigned to QUADEX PHARMACEUTICALS LLC · Expires 2013-08-08 · 13y expired

What this patent protects

Patent listed against glycopyrronium-tosylate.

Drugs covered by this patent

glycopyrronium-tosylate (GLYCOPYRRONIUM TOSYLATE)

Patent Metadata

Patent number: AU2012209412A1
Jurisdiction: AU
Classification: —
Expires: 2013-08-08
Drug substance claim: No
Drug product claim: No
Assignee: QUADEX PHARMACEUTICALS LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.